SKI Market

Indian Indices

Nifty

26,046.95 148.40
(0.57%)

Sensex

85,267.66 449.53
( 0.53%)

Bank Nifty

59,389.95 180.10
( 0.30%)

Nifty IT

38,274.75 177.75
( 0.47%)

Global Indices

Nasdaq

48,475.79 -249.23
(-0.51%)

Dow Jones

6,848.05 -73.95
(-1.07%)

Hang Seng

50,843.93 695.11
(1.39%)

Nikkei 225

9,668.36 -34.80
(-0.36%)

Forex

USD-INR

90.19 0.30
(0.34%)

EUR-INR

105.70 1.00
(0.96%)

GBP-INR

120.75 0.96
(0.80%)

JPY-INR

0.58 0.01
(0.91%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5600262

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

23.58

122555.05

EPS(TTM)

Face Value()

Div & Yield %

64.35

1.05

Back

Mangalam Global Enterprise Ltd - Board Meeting Outcome For Submission Of Standalone & Consolidated Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025.

Oct 15,2025

Submission of Standalone and Consolidated Unaudited Financial Result for the Quarter and Half year ended September 30 2025

26,046.95 148.40 (0.57%)

85,267.66 449.53 ( 0.53%)

59,389.95 180.10 ( 0.30%)

38,274.75 177.75 ( 0.47%)

48,475.79 -249.23 (-0.51%)

6,848.05 -73.95 (-1.07%)

50,843.93 695.11 (1.39%)

9,668.36 -34.80 (-0.36%)

90.19 0.30 (0.34%)

105.70 1.00 (0.96%)

120.75 0.96 (0.80%)

0.58 0.01 (0.91%)